Skip to main content
The BMJ logoLink to The BMJ
letter
. 1993 Jul 17;307(6897):203–204. doi: 10.1136/bmj.307.6897.203-c

Management of heparin induced thrombocytopenia.

H N Magnani
PMCID: PMC1678357  PMID: 8343768

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chong B. H., Ismail F., Cade J., Gallus A. S., Gordon S., Chesterman C. N. Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172. Blood. 1989 May 1;73(6):1592–1596. [PubMed] [Google Scholar]
  2. Demers C., Ginsberg J. S., Brill-Edwards P., Panju A., Warkentin T. E., Anderson D. R., Turner C., Kelton J. G. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood. 1991 Nov 1;78(9):2194–2197. [PubMed] [Google Scholar]
  3. Krishnamurti C., Bolan C. D., Reid T. J., 3rd, Alving B. M. Pharmacology and mechanism of action of ancrod: potential for inducing thrombosis. Blood. 1992 May 1;79(9):2492–2492. [PubMed] [Google Scholar]
  4. Soutar R. L., Ginsberg J. S. Uses of heparin. Ancrod for heparin induced thrombocytopenia. BMJ. 1993 May 22;306(6889):1410–1410. doi: 10.1136/bmj.306.6889.1410-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES